Valvular aortic stenosis in the elderly.

Abstract:

:Elderly patients with valvular aortic stenosis have an increased prevalence of coronary risk factors, of coronary artery disease, and evidence of other atherosclerotic vascular diseases. Statins may reduce the progression of aortic stenosis (AS). Angina pectoris, syncope or near syncope, and congestive heart failure are the 3 classic manifestations of severe AS. Prolonged duration and late peaking of an aortic systolic ejection murmur best differentiate severe AS from mild AS on physical examination. Doppler echocardiography is used to diagnose the prevalence and severity of AS. The indications for cardiac catheterization and the medical management of AS are discussed. Once symptoms develop, aortic valve replacement (AVR) should be performed in patients with severe or moderate AS. Other indications for AVR are discussed. Warfarin should be administered indefinitely after AVR in patients with a mechanical aortic valve and in patients with a bioprosthetic aortic valve who have either atrial fibrillation, prior thromboembolism, left ventricular systolic dysfunction, or a hypercoagulable condition. Patients with a bioprosthetic aortic valve without any of these 4 risk factors should be treated with aspirin 75-100 mg daily.

journal_name

Cardiol Rev

journal_title

Cardiology in review

authors

Aronow WS

doi

10.1097/CRD.0b013e31805f6796

subject

Has Abstract

pub_date

2007-09-01 00:00:00

pages

217-25

issue

5

eissn

1061-5377

issn

1538-4683

pii

00045415-200709000-00001

journal_volume

15

pub_type

杂志文章,评审
  • Percutaneous mitral heart valve repair--MitraClip.

    abstract::Mitral regurgitation (MR) is the most common cardiac valvular disease in the United States. Approximately 4 million people have severe MR and roughly 250,000 new diagnoses of MR are made each year. Mitral valve surgery is the only treatment that prevents progression of heart failure and provides sustained symptomatic ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000036

    authors: Doshi JV,Agrawal S,Garg J,Paudel R,Palaniswamy C,Doshi TV,Gotsis W,Frishman WH

    更新日期:2014-11-01 00:00:00

  • Work-related psychosocial factors and the development of ischemic heart disease: a systematic review.

    abstract::The literature on the relationship between work-related psychosocial factors and the development of ischemic heart disease (IHD) was systematically reviewed: 33 articles presented 51 analyses of studies involving male participants, 18 analyses involving female participants, and 8 analyses with both genders. Twenty of ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e318198c8e9

    authors: Eller NH,Netterstrøm B,Gyntelberg F,Kristensen TS,Nielsen F,Steptoe A,Theorell T

    更新日期:2009-03-01 00:00:00

  • Pulmonary arterial hypertension and women.

    abstract::Pulmonary arterial hypertension (PAH) is a progressive disorder with a poor prognosis. It is characterized by sustained elevation of pulmonary artery pressure (PAP) and pulmonary vascular resistance (PVR). It is defined hemodynamically by a mean PAP over 25 mm Hg, a pulmonary arterial wedge pressure of 15 mm Hg or les...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000240529.49704.2e

    authors: De Marco T

    更新日期:2006-11-01 00:00:00

  • Women do benefit from lipid lowering: latest clinical trial data.

    abstract::Cardiovascular disease is the leading cause of morbidity and mortality among women in industrialized nations. Optimizing cardiovascular risk reduction is therefore of paramount importance, particularly among postmenopausal women, in whom the incidence of cardiovascular disease is highest. Accumulated data from a serie...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200301000-00003

    authors: Mostaghel E,Waters D

    更新日期:2003-01-01 00:00:00

  • Obesity and cardiovascular disease risk: research update.

    abstract::The obesity epidemic has reached unprecedented proportions in Western society. Evidence continues to accumulate that obesity is associated with significant morbidity and mortality and in particular that it is an independent risk factor for cardiovascular disease (CVD). The association of obesity with CVD and its risk ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200107000-00005

    authors: Melanson KJ,McInnis KJ,Rippe JM,Blackburn G,Wilson PF

    更新日期:2001-07-01 00:00:00

  • Predictors of Outcomes in Myocardial Infarction and Cardiogenic Shock.

    abstract::Myocardial infarction (MI) complicated by cardiogenic shock (MI-CS) is a major cause of cardiovascular morbidity and mortality. Predictors of outcomes in MI-CS include clinical, laboratory, radiologic variables, and management strategies. This article reviews the existing literature on short- and long-term predictors ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000190

    authors: Acharya D

    更新日期:2018-09-01 00:00:00

  • Role of Antiplatelet Therapy and Anticoagulation in Nonischemic Cardiomyopathy.

    abstract::Heart failure continues to be a leading cause of morbidity and mortality throughout the United States. The pathophysiology of heart failure involves the activation of complex neurohormonal pathways, many of which mediate not only hypertrophy and fibrosis within ventricular myocardium and interstitium, but also activat...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000094

    authors: Carazo M,Berger JS,Reyentovich A,Katz SD

    更新日期:2016-09-01 00:00:00

  • Congenital heart disease in pregnancy.

    abstract::Care of pregnant patients with congenital heart disease requires understanding of the specific congenital defect, the nature of previous surgical correction, and the residua and sequelae. General risks and principles can be adduced in management decisions. In addition, lesion- and patient-specific details are importan...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200008030-00007

    authors: Colman JM,Sermer M,Seaward PG,Siu SC

    更新日期:2000-05-01 00:00:00

  • Pacemakers and store security devices.

    abstract::The ever-increasing complexity of medical device therapy and installation of public electronic security systems demands vigilance in discerning interactions that may be harmful to patients during typical activities of daily living. Premature pacemaker stimulation, isolated skipped beats, or reversion to backup asynchr...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200101000-00004

    authors: Harthorne JW

    更新日期:2001-01-01 00:00:00

  • Ticagrelor: a novel reversible oral antiplatelet agent.

    abstract::The complex mechanism of platelet activation creates an optimal target for pharmacological treatment in patients with acute coronary syndromes. Current antiplatelet medications that are used in addition to aspirin include the thienopyridines, clopidogrel and prasugrel, but there are several limitations to the use of t...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182099d86

    authors: Nawarskas JJ,Clark SM

    更新日期:2011-03-01 00:00:00

  • Cardiac rupture after myocardial infarction: new insights from murine models.

    abstract::Cardiac rupture after a myocardial infarction is an uncommon event with devastating consequences. Although the clinical features of rupture have been described, the genetic and molecular influences on this outcome in patients are less certain. In mice, at least 17 genetic models have been developed that enhance or sup...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181bf4ab4

    authors: Sane DC,Mozingo WS,Becker RC

    更新日期:2009-11-01 00:00:00

  • Myocardial viability and microvascular obstruction: role of cardiac magnetic resonance imaging.

    abstract::Established coronary artery disease has a prevalence of 7% in adult Americans, accounting for 16 million people. As morbidity and mortality rates have risen, research efforts to identify the pathophysiologic mechanisms of systolic dysfunction have risen in parallel. The current goal is to develop new therapeutic strat...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000024

    authors: Romero J,Lupercio F,Haramati LB,Garcia MJ,Lucariello RJ

    更新日期:2014-09-01 00:00:00

  • Reverse Remodeling in Systolic Heart Failure.

    abstract::Left ventricular (LV) remodeling is the most common term used to describe the functional, structural, myocellular, and interstitial changes that occur in response to myocardial injury and/or chronic changes in myocardial loading conditions. Progression of LV remodeling over time in response to neurohormonal activation...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000068

    authors: Saraon T,Katz SD

    更新日期:2015-07-01 00:00:00

  • Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic.

    abstract::The effect of an ongoing educational program on the use of cardiovascular drugs in patients with coronary artery disease without contraindications to these drugs seen in an academic cardiology clinic was assessed in 100 patients seen during the 6-month period prior to the educational program and in 200 patients seen 9...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000131191.57664.e7

    authors: Nayak D,Aronow WS

    更新日期:2005-03-01 00:00:00

  • Inflammatory Cardiomyopathy: Case-based Review on Clinical Presentation, Diagnosis, and Management.

    abstract::Inflammatory cardiomyopathy is a broad term encompassing any disease leading to myocardial inflammation with associated cardiac dysfunction. While endomyocardial biopsy remains the gold standard for diagnosis, non-invasive imaging techniques, such as cardiac magnetic resonance imaging and positron emission tomography,...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/CRD.0000000000000369

    authors: Li B,Lento PA,Pan S

    更新日期:2020-11-02 00:00:00

  • Newer anticoagulants in cardiovascular disease: a systematic review of the literature.

    abstract::Vitamin K antagonists (VKAs) such as warfarin have traditionally been the major therapeutic option for anticoagulation in clinical practice. VKAs are effective and extensively recommended for the prevention of venous and arterial thromboembolism in cardiovascular disease. Despite its effectiveness, warfarin is limited...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3182503e2d

    authors: Maan A,Padmanabhan R,Shaikh AY,Mansour M,Ruskin JN,Heist EK

    更新日期:2012-09-01 00:00:00

  • Cardiac Resynchronization Therapy: Maximizing the Response to Biventricular Pacing.

    abstract::Cardiac resynchronization therapy (CRT) has become a mainstay therapy to improve clinical outcomes of patients with left ventricular systolic dysfunction and a wide QRS complex, in addition to guideline-directed medical therapy. As clinical experience with CRT continues to expand, the device and lead design, along wit...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000127

    authors: Ng CY,Heist EK

    更新日期:2017-01-01 00:00:00

  • Role of infection in atherosclerosis and coronary artery disease: a new therapeutic target?

    abstract::There is growing evidence that inflammatory processes may be involved in the development of atherosclerosis and its complications. Viral and bacterial pathogens have been implicated as possible causative factors in the pathogenesis of coronary artery disease and postangioplasty restenosis. Antibiotic trials have been ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200207000-00004

    authors: Frishman WH,Ismail AA

    更新日期:2002-07-01 00:00:00

  • Confusion in revascularization: are women different and why?

    abstract::Cardiovascular disease is the leading cause of death in women in most developed countries of the world. Even though cardiovascular deaths of men in the United States have been declining, until recently the number of cardiovascular deaths in US women was on the rise, with 1 in 3 women dying from heart disease. Over the...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e31815cb185

    authors: Dullum MK,Dullum MK

    更新日期:2008-01-01 00:00:00

  • Heat shock proteins in cardiovascular disease a new therapeutic target.

    abstract::Cells have the capability of defending themselves from various stressors by activating a genetic program with the production of substances known as heat shock proteins and their regulatory partners, the heat shock transcription factors. In this article, heat shock proteins are discussed, including their roles in patho...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000090894.70619.fa

    authors: Gupta M,Vavasis C,Frishman WH

    更新日期:2004-01-01 00:00:00

  • Implications of the New National Guidelines for Hypertension.

    abstract::Automated validated devices should be used for measuring blood pressure (BP). A systolic BP between 120 and 129 mm Hg with a diastolic BP < 80 mm Hg should be treated by lifestyle measures. Lifestyle measures plus BP lowering drugs should be used for secondary prevention of recurrent cardiovascular disease (CVD) event...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000187

    authors: Aronow WS,Frishman WH

    更新日期:2018-03-01 00:00:00

  • Pulmonary artery hypertension: caveolin-1 and eNOS interrelationship: a new perspective.

    abstract::Pulmonary artery hypertension (PAH) is a sequela of a number of disparate diseases, often with a fatal consequence. Endothelial dysfunction is considered to be an early event during the development of PAH. Impaired availability of bioactive nitric oxide (NO) is a key underlying feature in most forms of clinical and ex...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000249381.49138.b9

    authors: Mathew R,Huang J,Gewitz MH

    更新日期:2007-05-01 00:00:00

  • Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?

    abstract::Cholesterol metabolism and transport has been a major focus in cardiovascular disease risk modification over the past several decades. Hydroxymethylglutaryl-CoA reductase inhibitors (statins) have been the most commonly used agents, with the greatest benefit in reducing both the primary and secondary risks of cardiova...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000245

    authors: Grabie M,Tai CH,Frishman WH

    更新日期:2019-09-01 00:00:00

  • Evacetrapib: Another CETP Inhibitor for Dyslipidemia With No Clinical Benefit.

    abstract::Evacetrapib is a cholesteryl ester transfer protein (CETP) inhibitor that has been recently studied as a cholesterol modifying agent to reduce cardiovascular risk and mortality in high risk cardiovascular disease patients. Evacetrapib acts to decrease lipid exchange through CETP inhibition. CETP acts to transfer chole...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000137

    authors: Eyvazian VA,Frishman WH

    更新日期:2017-03-01 00:00:00

  • Endothelin as a clinical target in the treatment of systemic hypertension.

    abstract::Endothelin is a potent vasoconstrictor substance that also can exert proliferative, inflammatory, and fibrotic changes in blood vessels and other organs. It acts on tissues in a paracrine and autocrine fashion, with local production and regulation occurring in both endothelial and nonendothelial cells. Endothelin stim...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0b013e3181aa8f4a

    authors: Prasad VS,Palaniswamy C,Frishman WH

    更新日期:2009-07-01 00:00:00

  • What is the Brugada syndrome?

    abstract::In 1992, Brugada and Brugada reported a distinct subgroup of patients with episodes of "idiopathic"polymorphic ventricular tachycardia or ventricular fibrillation characterized by a unique electrocardiographic (ECG) pattern, which consisted of right bundle branch block and ST-segment elevation from V1 to V2-V3. As in ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-199907000-00010

    authors: Corrado D,Buja G,Basso C,Nava A,Thiene G

    更新日期:1999-07-01 00:00:00

  • Coronary artery rupture associated with amphetamine abuse.

    abstract::We report a case of spontaneous coronary artery rupture associated with amphetamine abuse in a 31-year-old woman. The patient presented to the emergency department with sudden onset of central chest pain and a normal electrocardiogram. Cardiac enzymes were consistent with acute myocardial infarction. Drug screening wa...

    journal_title:Cardiology in review

    pub_type: 杂志文章

    doi:10.1097/01.crd.0000132372.38506.45

    authors: Brennan K,Shurmur S,Elhendy A

    更新日期:2004-09-01 00:00:00

  • Heart Failure With Preserved Ejection Fraction: What Is in a Name?

    abstract::Evidence-based management of heart failure (HF) with preserved left ventricular ejection fraction (LVEF; HFpEF) remains a major gap in the care of patients with HF. Clinical trials directed toward the population with HFpEF have been disappointing, although renin-angiotensin-aldosterone system blockade appears to preve...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/CRD.0000000000000057

    authors: Jumean MF,Konstam MA

    更新日期:2015-07-01 00:00:00

  • Diagnosis and management of renovascular hypertension.

    abstract::Renovascular hypertension caused by renal artery stenosis accounts for a small portion of overall hypertension but remains important as the most common potentially curable form of high blood pressure. Diagnosis depends on developing an index of suspicion for renovascular hypertension based on the history and physical ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/00045415-200008010-00005

    authors: Klassen PS,Svetkey LP

    更新日期:2000-01-01 00:00:00

  • Mitral valve endocarditis resulting from coagulase-negative Staphylococcus after stent implantation in a saphenous vein graft.

    abstract::Valvular endocarditis after percutaneous coronary intervention is unusual. We report a new case of mitral valve endocarditis after stent implantation to a saphenous vein graft. ...

    journal_title:Cardiology in review

    pub_type: 杂志文章,评审

    doi:10.1097/01.crd.0000128842.48947.21

    authors: Palmer ND,Ramsdale DR

    更新日期:2005-05-01 00:00:00